These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3157826)
41. Factors influencing remission phase in children with type 1 diabetes mellitus. Büyükgebiz A; Cemeroglu AP; Böber E; Mohn A; Chiarelli F J Pediatr Endocrinol Metab; 2001; 14(9):1585-96. PubMed ID: 11795651 [TBL] [Abstract][Full Text] [Related]
42. [The effect of insulin therapy on the immune status of patients with newly detected diabetes mellitus]. Sliusarenko NS; Taranova NB Lik Sprava; 1994; (3-4):102-3. PubMed ID: 7975524 [TBL] [Abstract][Full Text] [Related]
43. Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes. Battaglia M; Roncarolo MG Semin Immunol; 2011 Jun; 23(3):182-94. PubMed ID: 21831659 [TBL] [Abstract][Full Text] [Related]
44. Immunotherapy in type I diabetes. Approaches to prevention and treatment. Colman PG; Eisenbarth GS Postgrad Med; 1987 May; 81(6):146-55. PubMed ID: 3554198 [TBL] [Abstract][Full Text] [Related]
45. Interactions between islets and regulatory immune cells in health and type 1 diabetes. Budd MA; Monajemi M; Colpitts SJ; Crome SQ; Verchere CB; Levings MK Diabetologia; 2021 Nov; 64(11):2378-2388. PubMed ID: 34550422 [TBL] [Abstract][Full Text] [Related]
46. Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray. Woittiez NJ; Roep BO Immunotherapy; 2015; 7(2):163-74. PubMed ID: 25713991 [TBL] [Abstract][Full Text] [Related]
48. New trends in diabetes research: the search for an etiologically oriented treatment for type I diabetes mellitus. Eizirik DL; Migliorini RH Braz J Med Biol Res; 1983 Dec; 16(4):381-3. PubMed ID: 6201223 [TBL] [Abstract][Full Text] [Related]
50. In light of recent clinical trial results, what lies next for Type 1 diabetes vaccine research? Ludvigsson J Expert Rev Vaccines; 2012 Mar; 11(3):263-5. PubMed ID: 22380817 [No Abstract] [Full Text] [Related]
51. Innovative immunological strategies for type 1 diabetes. Vives-Pi M; Pujol-Autonell I Endocrinol Nutr; 2015 Nov; 62(9):419-21. PubMed ID: 26342847 [No Abstract] [Full Text] [Related]
52. Vitamin D3 supplementation to preserve pancreatic β-cell function in newly diagnosed type 1 diabetic patients. Magge SN Arch Pediatr Adolesc Med; 2012 Jul; 166(7):664-6. PubMed ID: 22751886 [No Abstract] [Full Text] [Related]
53. [Ultrastructure of the peripheral blood lymphocytes in children with diabetes mellitus]. Smiian AI; Smorshchok SA Probl Endokrinol (Mosk); 1984; 30(4):14-8. PubMed ID: 6473313 [TBL] [Abstract][Full Text] [Related]
54. Immune Intervention for Type 1 Diabetes. Nambam B; Bratina N; Schatz D Diabetes Technol Ther; 2018 Feb; 20(S1):S86-S93. PubMed ID: 29437480 [No Abstract] [Full Text] [Related]
56. [Insulin resistance of immunological origin in an insulin-dependent diabetic patient]. Coutarel P; Doumith R; Bosquet F; Grimaldi A Rev Med Interne; 1987; 8(5):534. PubMed ID: 3445036 [No Abstract] [Full Text] [Related]
57. Defining a cure for type 1 diabetes: a call to action. Roep BO; Montero E; van Tienhoven R; Atkinson MA; Schatz DA; Mathieu C Lancet Diabetes Endocrinol; 2021 Sep; 9(9):553-555. PubMed ID: 34339632 [No Abstract] [Full Text] [Related]
58. Depleting T cells in newly diagnosed autoimmune (type 1) diabetes--are we getting anywhere? Lernmark Å Diabetes; 2013 Nov; 62(11):3669-70. PubMed ID: 24158996 [No Abstract] [Full Text] [Related]
59. [Diabetes by immunotherapy]. Manzano N; Ocampo P; Nicolini C; Halac S; Aguirre M; Rivero S; Zylberman M Medicina (B Aires); 2018; 78(1):60. PubMed ID: 29360082 [No Abstract] [Full Text] [Related]
60. [Immunotherapy of type 1 diabetes mellitus: current state-of-the-art and prospects. Part 2]. Laptev DN Probl Endokrinol (Mosk); 2009 Oct; 55(5):31-38. PubMed ID: 31569853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]